Cytokine gene expression during the elicitation phase of contact sensitivity: Regulation by endogenous IL-4

被引:61
作者
Asada, H [1 ]
Linton, J [1 ]
Katz, SI [1 ]
机构
[1] NCI,DERMATOL BRANCH,BETHESDA,MD 20892
关键词
T-helper cells TH1 and Th2; mRNA;
D O I
10.1111/1523-1747.ep12289700
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Recent studies have focused on characterizing the cytokine profile produced in the epidermis during the sensitization phase of contact sensitivity (CS). Some prior studies have also identified altered individual cytokine mRNA profiles in skin or draining lymph nodes (or several cytokine mRNA profiles in the epidermis) during the elicitation phase of CS. In this study we determined the dynamics of appearance of a battery of cytokine mRNA levels in both the epidermis and dermis during the elicitation phase of CS. We isolated mRNA from dispase-separated epidermis and dermis of TNCB-sensitized and naive BALB/c mice at various times after TNCB challenge, Changes in IFN-gamma and IL-4 mRNA levels (by semiquantitative RT-PCR) were more reproducible and dramatic than those of other cytokines studied (IL-1 beta, IL-2, IL-10, and IL-12 p40), Compared to naive mice, sensitized mice had significantly elevated IL-4 mRNA signals 9 and 24 h (dermis), and 24 h (epidermis), after TNCB challenge, The increased IL-4 mRNA levels were mast-cell-independent, because sensitized mast-cell-deficient mice showed similar increases in IL-4 mRNA. To examine the role of endogenous IL-4 in CS elicitation, sensitized mice were treated with anti-IL-4 mAb Ih before challenge. In accord with prior studies, anti-IL-4 mAb-pretreated mice showed increased ear swelling 24 h after challenge compared to mice pretreated with isotype control mAb, Anti-IL4 mAb pretreatment also enhanced IFN-gamma, IL-2, IL-12 p40, and IL-1 beta (but not IL-10) mRNA signals in the dermis of sensitized and challenged mice, These data indicate that IL-4 is produced in murine skin during the elicitation phase of CS and is an important down-modulator of inflammation. IL-4 may blunt CS by regulating local production of proinflammatory cytokines.
引用
收藏
页码:406 / 411
页数:6
相关论文
共 40 条
  • [1] AOKI I, 1995, P NATL ACAD SCI USA, V92, P25344
  • [2] INTERLEUKIN-10 BUT NOT INTERLEUKIN-4 IS A NATURAL SUPPRESSANT OF CUTANEOUS INFLAMMATORY RESPONSES
    BERG, DJ
    LEACH, MW
    KUHN, R
    RAJEWSKY, K
    MULLER, W
    DAVIDSON, NJ
    RENNICK, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01) : 99 - 108
  • [3] INTERLEUKIN-4 IS LOCALIZED TO AND RELEASED BY HUMAN MAST-CELLS
    BRADDING, P
    FEATHER, IH
    HOWARTH, PH
    MUELLER, R
    ROBERTS, JA
    BRITTEN, K
    BEWS, JPA
    HUNT, TC
    OKAYAMA, Y
    HEUSSER, CH
    BULLOCK, GR
    CHURCH, MK
    HOLGATE, ST
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) : 1381 - 1386
  • [4] B-CELL STIMULATORY FACTOR-I INTERLEUKIN-4 MESSENGER-RNA IS EXPRESSED BY NORMAL AND TRANSFORMED MAST-CELLS
    BROWN, MA
    PIERCE, JH
    WATSON, CJ
    FALCO, J
    IHLE, JN
    PAUL, WE
    [J]. CELL, 1987, 50 (05) : 809 - 818
  • [5] CHER DJ, 1987, J IMMUNOL, V138, P3688
  • [6] THE ROLE OF HELPER T-CELL PRODUCTS IN MOUSE B-CELL DIFFERENTIATION AND ISOTYPE REGULATION
    COFFMAN, RL
    SEYMOUR, BWP
    LEBMAN, DA
    HIRAKI, DD
    CHRISTIANSEN, JA
    SHRADER, B
    CHERWINSKI, HM
    SAVELKOUL, HFJ
    FINKELMAN, FD
    BOND, MW
    MOSMANN, TR
    [J]. IMMUNOLOGICAL REVIEWS, 1988, 102 : 5 - 28
  • [7] EARLY MOLECULAR EVENTS IN THE INDUCTION-PHASE OF CONTACT SENSITIVITY
    ENK, AH
    KATZ, SI
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (04) : 1398 - 1402
  • [8] EXTRACTION AND QUANTITATION OF CYTOKINE MESSENGER-RNA FROM HUMAN EPIDERMAL BLISTER ROOFS
    ENK, CD
    KATZ, SI
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 1994, 287 (01) : 72 - 77
  • [9] SWITCH OF CD8 T-CELLS TO NONCYTOLYTIC CD8-CD4- CELLS THAT MAKE T(H)2 CYTOKINES AND HELP B-CELLS
    ERARD, F
    WILD, MT
    GARCIASANZ, JA
    LEGROS, G
    [J]. SCIENCE, 1993, 260 (5115) : 1802 - 1805
  • [10] ESSNER R, 1989, J IMMUNOL, V142, P3857